Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Recurrence × Brachytherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Uterine Cervical Neoplasms 7 Hyperthermia 2 Endometrial Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Locally Advanced Cervical Adenocarcinoma 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Clear Cell Adenocarcinoma 1 Directly Observed Therapy 1 Carcinoma, Renal Cell 1 Adenocarcinoma 1

Interventions

venetoclax 19 Cyclophosphamide 17 pembrolizumab 15 Dexamethasone 15 Cytarabine 12 fludarabine 11 Azacitidine 11 Gemcitabine 9 pomalidomide 8 glofitamab 7 Rituximab 7 Lenalidomide 7 Carboplatin 7 selinexor 6 Temozolomide 6 Granulocyte Colony-Stimulating Factor 6 fludarabine phosphate 5 daratumumab 5 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 Injections 5 Cisplatin 5 zanubrutinib 4 ruxolitinib 4 obinutuzumab 4 carfilzomib 4 Surgical Procedures, Operative 4 Immunotherapy, Adoptive 4 Decitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05715502 2025-04-30

FocaSaBra

The Greater Poland Cancer Centre

Phase NA Recruiting

Prostatic Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡